Slfn proteins in innate immunity

描述(由申请人提供)：寄主生物体对入侵病原体的快速识别对于建立有效的免疫反应至关重要。病原体上保守的结构特征称为PAMP，由Toll样细胞表面受体识别，Toll样细胞表面受体是进化保守的先天免疫系统的一部分。我们先前发现干扰素调节因子3(IRF3)的激活和随后干扰素刺激基因(ISGs)的诱导是由TLR配体启动的一种新的信号通路。我们已经将这一途径定性为感染性休克综合征的主要贡献者，但也发现IRF-3激活级联是细菌毒素如炭疽芽孢杆菌致死因子的靶标。最近，我们研究了一个新的脂多糖和干扰素诱导的核酸结合蛋白家族(schlafen=slfn)，其成员似乎可以改变IRF3，但不能改变NF：B介导的对TLR配体的转录反应。本研究旨在研究SLFn蛋白在IRF3介导的天然免疫反应中的作用。我们推测，SLFN家族中较长的成员要么直接作为外源核酸的细胞质感受器，要么可能作为这种感觉蛋白的辅助因子，而细胞中和短的SLFN亚型以及病毒的SLFN蛋白具有减弱先天免疫反应的功能。实验被用来表征SLFN功能的特异性，确定它们在IRF3激活级联中的作用点，并鉴定SLFN相互作用的蛋白质。这些研究结果不仅将有助于我们理解IRF3的激活机制，而且将有助于阐明SLFN蛋白在生理和病理过程中作为天然免疫反应的新的调节器的作用。 公共卫生相关性：IRF3是TLR诱导反应的关键介体之一。缺乏IRF3激活会导致免疫反应的固定化，但在脓毒症过程中，这一途径的减弱可能是有益的。因此，对调节IRF3激活的因素，如SLFN蛋白的详细了解，可能为感染疾病过程中的药物干预提供新的靶点。

DESCRIPTION (provided by applicant): Rapid recognition of invading pathogens by the host organism is crucial in mounting an effective immune response. Conserved structural features on pathogens termed PAMPs are recognized by the Toll-like cell surface receptors, which are part of the evolutionary conserved innate immune system. We had previously identified the activation of Interferon Regulatory Factor 3 (IRF3) and the subsequent the induction of Interferon Stimulated Genes (ISGs) as a novel signaling pathway that is initiated by TLR ligands. We have characterized this pathway as a major contributor to septic shock syndrome, but also found that the IRF-3 activation cascade is a target for bacterial toxins such a Bacillus anthracis Lethal Factor. Recently, we studied a novel family of LPS and interferon-induced nucleic acid binding proteins (schlafen = slfn) whose members appear to alter IRF3, but not NF:B mediated transcriptional responses towards TLR ligands. The proposed research is aimed towards investigating the function of the Slfn proteins in IRF3-mediated innate immune responses. We hypothesize that the longer members of the Slfn family act either as cytoplasmic sensors of foreign nucleic acids directly, or possibly as cofactors to such sensory proteins, whereas the medium and short cellular Slfn isoforms as well as the viral Slfn proteins function to attenuate the innate immune response. Experiments are proposed to characterize the specificity of Slfn function, to define their point-of-action in the IRF3 activation cascade, and to identify Slfn-interacting proteins. Results from these proposed studies will not only facilitate our understanding of the mechanism of IRF3 activation, but will also shed light on the role of Slfn proteins as novel modulators of the innate immune response under physiological and pathological processes. PUBLIC HEALTH RELEVANCE: IRF3 is one of the key mediators of TLR-induced responses. Lack of IRF3-activation leads to an immobilization of the immune response, yet attenuation of this pathway can be beneficial during septic processes. Thus, a detailed understanding of factors such as Slfn proteins that can modulate IRF3 activation is likely to provide novel targets for pharmacological intervention during infectious disease processes.